CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 228 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción CVLLY?
El precio actual de CVLLY es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de CellaVision AB?
CellaVision AB pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de CellaVision AB?
La capitalización bursátil actual de CellaVision AB es $0
¿Es CellaVision AB una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para CellaVision AB, incluyendo 2 fuerte compra, 5 compra, 1 mantener, 0 venta, y 2 fuerte venta
